The documented research dose is ~2.33 mg of total blend per administration, which for a 70 mg vial reconstituted in 3 mL equals 0.10 mL, or 10 units on a U-100 syringe
There is a deeper irony embedded in this practice: if buyers believed these products were safe, properly characterized and manufactured to the standards expected of pharmaceutical-grade products, they would not need to commission independent purity tests
The fundamental chemical instability of the peptide chain in a liquid solution at room temperature remains, making refrigeration essential regardless of preservatives
Research overview Other vial-size protocols Related protocols and comparisons
Although several laboratory and animal studies suggest potential regenerative effects, there are scant high-quality randomized controlled human trials demonstrating its safety or efficacy
Watch-outs to know: The FDA has flagged Semax as a peptide that might trigger an unwanted immune response, and it has raised concerns about impurity and lack of safety data in humans
